Evaluation of Rezum therapy as a minimally invasive modality for management of Benign Prostatic Hyperplasia: A prospective observational study. Arch Ital Urol Androl [Internet]. 2023 Dec. 28 [cited 2026 Jun. 2];95(4). Available from: https://www.pagepressjournals.org/aiua/article/view/12026